Learn More
The efficacy and specificity of treatment are major challenges for cancer gene therapy. Oncolytic virotherapy is an attractive drug delivery platform for cancer gene therapy. In the present study, the dual‑specific antitumor oncolytic adeno-virus, Ad‑Apoptin‑hTERT‑E1a, was used to infect SW1116 human colorectal carcinoma (CRC) cell lines and CT26(More)
  • 1